Search for: "Bristol-Myers Squibb Company " Results 421 - 440 of 465
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Apr 2008, 9:57 pm
  In March 2002, Sanofi-Synthelabo and Bristol-Myers Squibb sued Apotex for infringing the Orange Book-listed patent, U.S. [read post]
23 Apr 2008, 8:20 am
Back in the summer of 2006, drugmaker Bristol-Myers Squibb hit the skids when the feds investigated an agreement the company struck to delay the launch of a generic version of its blood-thinning drug, Plavix. [read post]
3 Apr 2008, 9:50 am
Safeway, CVS Caremark, and Bristol-Myers Squibb, like JCPenney now, amended their by-laws following an agreement with me that made a shareholder vote unnecessary. [read post]
28 Mar 2008, 7:25 am
Proponents have withdrawn resolutions at Abbott Laboratories, Aetna, Bristol-Myers Squibb, Eli Lilly, General Electric, IBM, Johnson & Johnson, McDonald's, Medco, WellPoint, ExxonMobil, Merck, Target, and Waste Management after many of the companies agreed to post statements on health care reform on their Web sites. [read post]
27 Mar 2008, 3:40 pm
The prosecution of Frederick Schiff, the former chief financial officer at Bristol-Myers Squibb Co., who was indicted with another former executive on securities fraud charges, is flailing. [read post]
12 Mar 2008, 9:17 am
Safeway's adoption of my poison pill by-law was preceded by an adoption last month by CVS Caremark, an adoption by Disney, and an adoption by Bristol-Myers Squibb. [read post]
7 Feb 2008, 12:43 pm
The adoption by CVS was preceded by an adoption by Disney, which adopted a version of my proposal after the proposal won 57% of the votes in Disney's annual meeting, as well as an adoption by Bristol-Myers Squibb. [read post]
4 Dec 2007, 6:33 pm
Bristol-Myers Squibb was the first company to develop and patent a liquid pharmaceutical composition of megestrol acetate and had a patent that taught that stable suspensions of megestrol acetate can be created but that the type and concentration of the surfactant in solution is critical to creating a stable flocculated suspension. [read post]
13 Nov 2007, 7:19 pm
The government's settlements with Bristol-Myers Squibb Co., Aventis Pharmaceuticals, Inc., Medco Health Solutions, Inc., Purdue Pharma L.P., Purdue Frederick Co., and InterMune, Inc. totalled over $800 million. [read post]
9 Nov 2007, 9:03 am
  In turn, GlaxoSmithKline could follow the lead of Bristol-Myers Squibb (BMS) when that drug company experienced increasing scrutiny about the safety of its antibiotic Tequin in 2006. [read post]
2 Oct 2007, 6:53 pm
By Sherri Oslick -- Last week, Bristol-Myers Squibb Co. of Princeton, NJ announced that it would acquire biotechnology company Adnexus Therapeutics Inc. of Waltham, MA for $430 million in cash (with an additional $75 million to be paid provided Adnexus meets certain regulatory milestones). [read post]
1 Oct 2007, 1:08 am
Bristol-Myers Squibb to Pay $515M to Settle Probes of Drug Marketing The Associated Press Bristol-Myers Squibb Co. and a former subsidiary have agreed to pay more than $515 million to settle federal and state investigations into their drug marketing and pricing practices. [read post]
29 Sep 2007, 10:48 pm
  The lawsuits alleged that between 2000 and 2003, Bristol-Myers Squibb offered kickbacks to physicians and other healthcare providers to get them to promote Bristol-Myers Squibb drugs. [read post]
29 Sep 2007, 9:21 pm
The United State Attorney for Massachusetts reports in a press release that "Bristol-Myers Squibb Company (BMS) and its wholly owned subsidiary, Apothecon, Inc., have agreed to pay in excess of $515 million to resolve a broad array of federal and... [read post]
28 Sep 2007, 12:51 pm
Article from WCVB TV/DT Boston -- Company To Pay $515M To Settle Drug Marketing Probes: Bristol-Myers Squibb Agrees To Settlement. [read post]
7 Sep 2007, 8:52 am
Schering-Plough, Coca-Cola, Bristol-Myers Squibb, and Prudential Financial were among the companies receiving inquiries, The Wall Street Journal reported. [read post]
20 Jul 2007, 7:39 pm
This week, shortly before trial, pharmaceutical manufacturer Bristol-Myers Squibb Co. reportedly agreed to pay $13 million to resolve allegations that it overcharged for its Taxol cancer medicine and other drugs. [read post]